Capmist DM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Capital Pharmaceutical, Llc. The primary component is Dextromethorphan Hydrobromide; Guaifenesin; Pseudoephedrine Hydrochloride.
Product ID | 29978-601_a0acda2e-9077-bf35-e053-2995a90a8092 |
NDC | 29978-601 |
Product Type | Human Otc Drug |
Proprietary Name | Capmist DM |
Generic Name | Dextromethorphan Hydrobromide, Guaifenesin And Pseudoephedrine Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-06-20 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Capital Pharmaceutical, LLC |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 15 mg/1; mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2013-06-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2013-06-20 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-12 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-06-20 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-12 |
Ingredient | Strength |
---|---|
DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/1 |
SPL SET ID: | 63733ac3-859e-4a8e-8717-d852bd303408 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
29978-601 | Capmist DM | Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride |
29978-606 | CAPMIST DM | CAPMIST DM |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CAPMIST DM 90709043 not registered Live/Pending |
Nevett, Michael 2021-05-13 |